EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes

Benjamin B Johnson, Marie-Victoire Cosson, Lorenza I Tsansizi, Terri L Holmes, Tegan Gilmore, Katherine Hampton, Ok-Ryul Song, Nguyen T N Vo, Aishah Nasir, Alzbeta Chabronova, Chris Denning, Mandy J Peffers und 6 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2023.113668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Benjamin B Johnson und 17 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Metabolic Health, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7UQ, UK. Hauptthemen laut MEDLINE: Heparan Sulfate Proteoglycans, Agrin. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, National Centre for the Replacement, Refinement and Reduction of Animals in Research, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heparan Sulfate ProteoglycansAgrinHumansMyocytes, CardiacExtracellular MatrixExtracellular Matrix Proteins

Stichwörter der Autor:innen

CP: Cell biologyCP: Developmental biologyagrincardiac maturationcardiomyocytesextracellular matrixheparan sulfate proteoglycanhuman pluripotent stem cellshypertrophymultinucleationperlecanperlecan mutation

Substanzen

perlecanHeparan Sulfate ProteoglycansAgrinExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Centre for Metabolic Health, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7UQ, UK.
  • The Francis Crick Institute, London NW1 1AT, UK; NHLI, Imperial College London, London, UK.
  • The Francis Crick Institute, London NW1 1AT, UK.
  • The Francis Crick Institute, London NW1 1AT, UK; High-Throughput Screening Science Technology Platform, The Francis Crick Institute, London NW1 1AT, UK.
  • School of Medicine, Regenerating and Modelling Tissues, Biodiscovery Institute, University Park, University of Nottingham, Nottingham NG7 2RD, UK.
  • Institute of Life Course and Medical Sciences, William Henry Duncan Building, 6 West Derby Street, Liverpool L7 8TX, UK.

Förderung

  • British Heart Foundation
  • National Centre for the Replacement, Refinement and Reduction of Animals in Research
  • Wellcome Trust

Zitieren

APA

Johnson, B. B., Cosson, M. V., Tsansizi, L. I., Holmes, T. L., Gilmore, T., Hampton, K., Song, O. R., Vo, N. T. N., Nasir, A., Chabronova, A., Denning, C., Peffers, M. J., Merry, C. L. R., Whitelock, J., Troeberg, L., Rushworth, S. A., Bernardo, A. S., & Smith, J. G. W. (2024). Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113668

Vancouver

Johnson BB, Cosson MV, Tsansizi LI, Holmes TL, Gilmore T, Hampton K, et al. Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes. Cell Reports. 2024. doi:10.1016/j.celrep.2023.113668

BibTeX
@article{Johnson2024,
  author = {Johnson, Benjamin B and Cosson, Marie-Victoire and Tsansizi, Lorenza I and Holmes, Terri L and Gilmore, Tegan and Hampton, Katherine and Song, Ok-Ryul and Vo, Nguyen T N and Nasir, Aishah and Chabronova, Alzbeta and Denning, Chris and Peffers, Mandy J and Merry, Catherine L R and Whitelock, John and Troeberg, Linda and Rushworth, Stuart A and Bernardo, Andreia S and Smith, James G W},
  title = {Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2023.113668}
}
Kostenlos starten →